DNA Script to present at the SynBioBeta conference in London

Paris, April the 3rd, 2017. DNA Script, a company focused on the manufacturing of synthetic DNA using a proprietary enzymatic technology, will present at the Synbiobeta conference on Tuesday, April the 4th at 3.35 p.m. in London, UK. The Synbiobeta Conference is a financial investor and strategic business partnering event focused on early stage companies in the life science field.

About DNA Script.

DNA Script is a Paris-based company focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology. The company aims at accelerating innovation in life sciences and technology through rapid, affordable and high-quality DNA synthesis. DNA Script leverages nature's billions of years of evolution in synthesizing DNA to enable genome scale synthesis.
Its technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemicals production, improved crops as well as data storage. DNA Script develops its technology in partnership with Institut Pasteur and Institut Pierre Gilles de Gennes with the support of key investors such as Sofinnova Partners, Kurma Partners and Idinvest Partners.

www.dnascript.co

Contact
Sylvain Gariel, COO
sg@dnascript.co
+33.6.28.04.53.11
www.dnascript.co
Made on
Tilda